Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Assessment of the Incidence and Severity of Internal Hernia and Bowel Obstruction at One Year Following Use of the MagDI System to Create Side-to-Side Duodeno-Ileal Magnetic Compression Anastomoses (MagDI US Registry)

NCT06928545 is registered in ClinicalTrials.gov with GT Metabolic Solutions, Inc. as lead sponsor.

NCT NCT06928545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06928545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Assessment of the Incidence and Severity of Internal Hernia and Bowel Obstruction at One Year Following Use of the MagDI System to Create Side-to-Side Duodeno-Ileal Magnetic Compression Anastomoses (MagDI US Registry)
Lead sponsor
GT Metabolic Solutions, Inc.
Phase
Observational
Overall status
Recruiting
Start date
March 28, 2025
Completion date
April 30, 2027
Enrollment
106 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anastomosis, surgical, bowel obstruction, internal hernia